drugset / Trial / NCT00108550

Chronic Low Back Pain Research Project

NCT00108550 ↗

Phase 2 Completed 108 enrolled US Department of Veterans Affairs
RandomizedParallel-groupTriple-blindTreatment

Summary

The purpose of this study is to determine whether gabapentin is efficacious as an analgesic for chronic low back pain.

Timeline

Start
2004-10
Primary completion
2009-07
Completion
2009-09

Outcome

Missed primary endpoint

registry analysis (superiority or other test); Placebo vs Gabapentin; p = 0.4237; Mean Difference (Final Values) 0.0305 (95% CI -0.044 to 0.105) NCT00108550 ↗

Drugs

EvaluationDrugModalityDoseRoute
Subject Gabapentin Unknown 3600 mg Oral

Indications